The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung cancer (SCLC). "Some cancer types are incredibly difficult to treat ...

“The most fundamental things you can ask of a bacterium: How does it grow and divide? How does it control its cell cycle? Those are things that we don’t understand for this pathogen,” Aldridge said.

A rare cell type in the lungs is essential to survival ... may keep the human immune system's initial counterattack on the virus (lung inflammation) from spiraling out of control to endanger ...

In announcing (Chinese) ivonescimab’s Chinese approval in first-line PD-L1-positive non-small cell lung cancer on Friday, Akeso noted that the bispecific drug slashed the risk of death by 22.3% ...

Research Pinpoints Weakness in Lung Cancer's Defenses Feb. 10, 2025 — Scientists uncover an enzyme that boosts cancer cell metabolism to fuel growth. The enzyme, GUK1, supports metabolism in ...

The U.S. is an outlier in recommending annual COVID-19 vaccination universally to adults without risk factors and to children, noted Shira Doron, MD, MS, of Tufts Medical Center in Boston ...

“Optune Lua is an innovative and urgently needed new approach for treating metastatic non-small cell lung cancer,” said Joachim Aerts, M.D., a LUNAR investigator and Professor of Pulmonary ...

the drug has generate promising results in advanced non-small cell lung cancer (NSCLC). Data from the TROPION-Lung02 reported at the World Congress on Lung Cancer (WCLC) showed an overall response ...

"Most patients treated for small cell lung cancer experience rapid progression of disease and there is a high unmet need in the advanced setting," he added. "These interim results from the first ...